Compounds

Details Compounds Compounds

2006-04-11

2006-04-11

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S274100, C544S317000, C544S331000, C544S333000

Reexamination Certificate

active

07026336

ABSTRACT:
Compounds of formula (I) wherein X is O, CH2, S or NH, or the moiety X—R1is hydrogen; V is CH or N; Y is NR10R11, NR10C(Z)NR10R11, NR10COOR11or NR10SO2R11; Ar is phenyl or a 5- or 6-membered heteroaryl ring either of which may be optionally substituted; n is 0, 1, 2, 3 or 4; and R1, R2, R3, R4, R10and R11have the meanings given in the description; and pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 3707475 (1972-12-01), Lombardino
patent: 4348404 (1982-09-01), Whitney
patent: 5166214 (1992-11-01), Billheimer et al.
patent: 5179117 (1993-01-01), Maduckuie, Jr.
patent: 5236917 (1993-08-01), Dunlap et al.
patent: 5310748 (1994-05-01), Wilde et al.
patent: 5514505 (1996-05-01), Limburg et al.
patent: 5552557 (1996-09-01), Fujii et al.
patent: 5620999 (1997-04-01), Weier et al.
patent: 5656644 (1997-08-01), Adams et al.
patent: 5717100 (1998-02-01), Selnick et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6040320 (2000-03-01), Beers et al.
patent: 6207687 (2001-03-01), Claiborne et al.
patent: 6235760 (2001-05-01), Feuerstein
patent: 6342510 (2002-01-01), Isakson et al.
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 6548520 (2003-04-01), Adams et al.
patent: 6602877 (2003-08-01), Bamborough et al.
patent: 2003/0134837 (2003-07-01), Gaiba et al.
patent: 2003/0153588 (2003-08-01), Steadman et al.
patent: 2004/0038964 (2004-02-01), Dean et al.
patent: 2004/0053943 (2004-03-01), Adams et al.
patent: 2004/0127496 (2004-07-01), Dean et al.
patent: 2004/0192689 (2004-09-01), Dean et al.
patent: 2004/0198730 (2004-10-01), Dean et al.
patent: 2004/0209883 (2004-10-01), Bamford et al.
patent: 2004/0235843 (2004-11-01), Bamford et al.
patent: 2004/0248896 (2004-12-01), Dean et al.
patent: 2004/0254186 (2004-12-01), Dean et al.
patent: WO 97/36587 (1997-10-01), None
patent: WO 98/16227 (1998-04-01), None
patent: WO 99/01449 (1999-01-01), None
patent: WO 99/32436 (1999-07-01), None
patent: WO 99/32455 (1999-07-01), None
patent: WO 99/61437 (1999-12-01), None
patent: WO 00/01688 (2000-01-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/33836 (2000-06-01), None
patent: WO 00/64422 (2000-11-01), None
patent: WO 01/37835 (2001-05-01), None
Mercer et al. {Biochimica et Biophysica Acta 1653 (2003) 25-40}.
Adams et al,Bioorganic & Medical Chemistry Letters, vol. 8 pp. 3111-3116 (1998).
Adams et al,Current Opinion in Drug Discovery and Development, vol. 2(2) pp. 96-109 (1999).
Antolini et al,Bioorganic & Medical Chemistry Letters, vol. 9 pp. 1023-1028 (1999).
Astles et al,J. Med. Chem., vol. 39 pp. 1423 (1996).
Bilodeau et al,J. Org. Chem., vol. 63 pp. 2800-2801 (1998).
Boehm et al,Exp Opinion Ther. Patents, vol. 10(1) (2000).
Boehm et al,J. Med Chem., vol. 39 pp. 3929-3937 (1996).
Claiborne et al,Tetrahedron Letters, vol. 39 pp. 8939-8942 (1998).
Cuenda A. et al,FEBS Letters, vol. 364 pp. 229-233 (1995).
de Laszlo et al,Bioorganic & Medical Chemistry Letters, vol. 8 pp. 2689-2694 (1998).
Dumas et al,Bioorganic & Medical Chemistry Letters, vol. 10 pp. 2047-2050 (2000).
Dumas et al,Bioorganic & Medical Chemistry Letters, vol. 10 2051-2054 (2000).
Eberwein et al,Clinical Cancer Researc, vol. 6 (Supple.) Poster session 17 pp. 4547(406) (Nov 2000).
Engel & Steglich,Liebigs Ann. Chem., p. 1916 (1978).
Fischer et al.,Rec.Trav.Chim.Pays.Bas., vol. 84 p439 (1965).
Gallagher et al,Bioorganic & Medical Chemistry, vol. 5(1) pp. 49-64 (1997).
Garcia-Echeverria et al,Med. Res. Reviews, vol. 20(1) pp. 28-57 (2000).
Garigipati, R.,Tetrahedron Letters, vol. 31,p. 190(1989).
Hall-Jackson et al,Oncogene, vol. 18 pp. 2047-2054 (1999).
Heimbrock et al, “Identification of Potent, Selective Inhibitors of Raf Protein Kinase”,Amer. Assoc for Cancer Res New OrleansApr. 1998.
Henry et al,Bioorganic & Medical Chemistry Letters, vol. 8 pp. 3335-3340 (1998).
Henry et al,Drugs of the Future, vol. 24(12) pp. 1345-1354 (1999).
Ishibashi,Chem. Pharm. Bull., vol. 37(8), pp. 2214-2216 (1989).
Johnson, P.A.,J.Chem.Soc., Perkin Trans., vol. 1, pp. 895-905 (1996).
Katritzky,Synthesis, pp. 45-47 (1993).
Kumada et al.,Tetrahedron Letters, vol. 22, p 5319 (1981).
Lackey et al,Bioorganic & Medical Chemistry Letters, vol. 10 pp. 223-226 (2000).
Lee et al,Pharmacol Ther., vol. 82(2-3) pp. 389-397 (1999).
Lisnock et al,BioChemistry, vol. 37 pp. 16573-16581 (1998).
Liverton et al,J. Med Chem., vol. 42 pp. 2180-2190 (1999).
Lowinger et al, Clinical Cancer Research, vol. 6(335) (Suppl.) Poster session 13 p. 4533 (Nov. 2000).
Morton et al.,Tetrahedron Letters, 4123 (1982).
Pridgen,J.Org.Chem., vol. 47, p. 4319 (1982).
R.P.Soni,Aust.J.Chem., vol. 35, pp. 1493-6 (1982).
Revesz et al,Bioorganic & Medical Chemistry Letters, vol. 10 pp. 1261-1264 (2000).
Salituro et al,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Snieckus, V.,Tetrahedron Letters, vol. 29, 2135 (1988).
Stille,J.Amer.Chem.Soc., vol. 109, p. 5478 (1978).
Stover et al,Current Opinion in Drug Discovery and Development, vol. 2(4) pp. 274-285 (1999).
Strzybny et al.,J. Org. Chem., vol. 28, p. 3381 (1963).
Terashimia, M.,Chem.Pharm.Bull., vol. 11, p. 4755 (1985).
Thompson, et al.,J.Org.Chem., vol. 49, p. 5237 (1984).
Toledo et al,Current Medicinal Chemistry, vol. 6 pp. 775-805 (1999).
Tong et al,Nature Structural Biology, vol. 4(4) p. 311 (1997).
Two Novel structural classes of p38 Kinase inhibitors,Exp Opin. Ther. Patentsvol. 9(4) pp. 477-480 (1999).
Uno, Bull.Chem. Soc. Japan., vol. 69, pp. 1763-1767 (1996).
VanLeusen et al.,J.O.C., vol. 42, p. 1153 (1977).
Vertex Pharmaceuticals,Exp Opin. Ther. Patents, vol. 10(7) pp. 1151-1154 (2000).
Wang et al,Stucture, vol. 6 pp. 1117-1128 (Sep. 15, 1998).
Young et al,The Journal of Biological Chemistry, vol. 272(18) pp. 12116-12121 (1997).
Zavyalov, et al.,Khim Farm Zh, vol. 26(3), p. 88 (1992) (With Translation).

Affiliated with

Also associated with

Rating

Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3605543